1. Home
  2. VVOS vs NCL Comparison

VVOS vs NCL Comparison

Compare VVOS & NCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • NCL
  • Stock Information
  • Founded
  • VVOS 2016
  • NCL 2013
  • Country
  • VVOS United States
  • NCL United States
  • Employees
  • VVOS N/A
  • NCL N/A
  • Industry
  • VVOS Medical Specialities
  • NCL
  • Sector
  • VVOS Health Care
  • NCL
  • Exchange
  • VVOS Nasdaq
  • NCL Nasdaq
  • Market Cap
  • VVOS 27.3M
  • NCL 30.7M
  • IPO Year
  • VVOS 2020
  • NCL 2023
  • Fundamental
  • Price
  • VVOS $3.07
  • NCL $0.12
  • Analyst Decision
  • VVOS Strong Buy
  • NCL
  • Analyst Count
  • VVOS 2
  • NCL 0
  • Target Price
  • VVOS $6.25
  • NCL N/A
  • AVG Volume (30 Days)
  • VVOS 492.4K
  • NCL 2.6M
  • Earning Date
  • VVOS 11-13-2025
  • NCL 11-18-2025
  • Dividend Yield
  • VVOS N/A
  • NCL N/A
  • EPS Growth
  • VVOS N/A
  • NCL N/A
  • EPS
  • VVOS N/A
  • NCL N/A
  • Revenue
  • VVOS $14,393,000.00
  • NCL $12,009,378.00
  • Revenue This Year
  • VVOS $16.05
  • NCL N/A
  • Revenue Next Year
  • VVOS $43.75
  • NCL N/A
  • P/E Ratio
  • VVOS N/A
  • NCL N/A
  • Revenue Growth
  • VVOS 2.65
  • NCL N/A
  • 52 Week Low
  • VVOS $1.98
  • NCL $0.12
  • 52 Week High
  • VVOS $7.95
  • NCL $1.52
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 36.25
  • NCL 47.66
  • Support Level
  • VVOS $2.96
  • NCL $0.12
  • Resistance Level
  • VVOS $3.41
  • NCL $1.03
  • Average True Range (ATR)
  • VVOS 0.24
  • NCL 0.02
  • MACD
  • VVOS 0.02
  • NCL 0.03
  • Stochastic Oscillator
  • VVOS 20.77
  • NCL 0.99

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About NCL Northann Corp.

Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. It offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, mainly through its sales network in North America and Europe.

Share on Social Networks: